Related Experiment Video

Updated: Sep 17, 2025

DNA Vector-based RNA Interference to Study Gene Function in Cancer
13:10

DNA Vector-based RNA Interference to Study Gene Function in Cancer

Published on: June 4, 2012

20.7K

Targeting YTHDF2 with pH-responsive siRNA nanoparticles suppresses MYC m6A modification and restores antitumor

Ziqi Guo1,2,3, Qiuling Huang1, Zhenzhen Cui1

  • 1College of Life Sciences, Guangxi Normal University, No. 15 Yucai Road, Qixing District, Guilin, Guangxi, 541004, China.

Journal of Nanobiotechnology
|July 2, 2025
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Hepatocellular carcinoma immunotherapyMyeloid-derived suppressor cellsYTHDF2m6A modificationpH-responsive nanoparticlessiRNA therapy

More Related Videos

Preparation of Neutrally-charged, pH-responsive Polymeric Nanoparticles for Cytosolic siRNA Delivery
09:09

Preparation of Neutrally-charged, pH-responsive Polymeric Nanoparticles for Cytosolic siRNA Delivery

Published on: May 2, 2019

7.6K
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

611

Related Experiment Videos

Last Updated: Sep 17, 2025

DNA Vector-based RNA Interference to Study Gene Function in Cancer
13:10

DNA Vector-based RNA Interference to Study Gene Function in Cancer

Published on: June 4, 2012

20.7K
Preparation of Neutrally-charged, pH-responsive Polymeric Nanoparticles for Cytosolic siRNA Delivery
09:09

Preparation of Neutrally-charged, pH-responsive Polymeric Nanoparticles for Cytosolic siRNA Delivery

Published on: May 2, 2019

7.6K
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

611

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K

Articles linked to this work by shared authors, journal, and citation graph.

A 3D-printed self-propelled, highly sensitive mini-motor for underwater pesticide detection.

Talanta·2018

Integrated analysis of microarray data to identify the genes critical for the rupture of intracranial aneurysm.

Oncology letters·2018

Photocatalytic Supramolecular Enantiodifferentiating Dimerization of 2-Anthracenecarboxylic Acid through Triplet-Triplet Annihilation.

Organic letters·2018

Advances in covalent organic frameworks in separation science.

Journal of chromatography. A·2018

On the realization of acoustic attenuation using a microperforated panel alone.

The Journal of the Acoustical Society of America·2018

Enhanced chiral recognition by γ-cyclodextrin-cucurbit[6]uril-cowheeled [4]pseudorotaxanes.

Chemical communications (Cambridge, England)·2018

Reprogramming microglia via ShK-modified extracellular vesicles promotes immunomodulation and functional recovery after spinal cord injury.

Journal of nanobiotechnology·2026

Responsive hydrogel delivery of DFO-programmed apoptotic bodies drives redox-immuno-angiogenic remodeling in diabetic wounds.

Journal of nanobiotechnology·2026

MHY@MO@PPP inhibits ferroptosis positive feedback and delays the acute kidney injury-to-chronic kidney disease transition by remodeling the Fe2+-mTORC1-GPX4 axis.

Journal of nanobiotechnology·2026

Ultrasound-activated Cu2-XSe/TiO2 heterostructured nanosonosensitizer enables coordinated induction of ferroptosis and cuproptosis for tumor immunotherapy.

Journal of nanobiotechnology·2026

Tumor cell membrane‑coated MOF‑199 nanoparticles co‑loaded with auranofin and celecoxib enhance single‑dose radiotherapy and anti‑PD‑L1 therapy in cervical cancer.

Journal of nanobiotechnology·2026

A tumor microenvironment acid-responsive therapy combining fenton chemistry and chemotherapy via TNF pathway for synergistic and safe lung cancer treatment.

Journal of nanobiotechnology·2026

Pharmacogenetics in HIV therapy: a review of key biomarkers, regulatory annotations, and clinical dosing guidelines.

Pharmacogenomics·2026

EXPRESS: A novel mouse model of cerebral venous sinus thrombosis based on photochemical-induction combined with in situ injection.

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism·2026

Ocular Gene Therapy in China: Technological Framework, Clinical Translation, and Future Perspectives.

Human gene therapy·2026

Targeting fibroimmune remodeling in androgenetic alopecia: emerging opportunities for RNA-based drug discovery.

Expert opinion on drug discovery·2026

[IDH-mutant gliomas. State of the art].

Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko·2026

Amniotic Epithelial Stem Cells-Derived Exosomes Attenuate the Lesion of Alveolar Epithelial Cells Induced by SARS-CoV-2 Spike Protein via SENP3- Triggered FGF9 deSUMOylation.

Advanced biology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us